The National Cancer Institute (NCI) has awarded a six-year, $8.9 million grant to Case Comprehensive Cancer Center, to enable the center to provide patients additional access to clinical trials through the National Clinical Trial Network.

Once again designated as a Lead Academic Participating Site, the center will work collaboratively with its three hospital partners including Cleveland Clinic, MetroHealth, and University Hospitals Seidman Cancer Center.  Patients will have access to the latest and most promising treatment options, reports Crain’s Cleveland Business.

Case Comprehensive has supported more than 1,000 clinical trial participating patients since 2014. The center is directed by Dr. Mitchell Machtay, co-principal investigator on the grant, as well as associate director for clinical research at the Case Comprehensive Cancer Center, and the Vincent K. Smith Professor and chairman of radiation oncology at Case Western Reserve University School of Medicine and UH Seidman Cancer Center.

Other key participating co-principal investigators include:

  • Dr. Aaron Gerds
  • Dr. Afshin Dowlati
  • Dr. Bruce Averbrook
  • Dr. David Adelstein
  • Dr. Jame Abraham
  • Dr. John Suh
  • Dr. Marcos de Lima
  • Dr. Mikkael Sekeres
  • Dr. Min Yao
  • Dr. Paolo Caimi
  • Dr. Peter Rose
  • Dr. Steven Waggoner

Case Western Reserve, is a private research university in Cleveland, Ohio. The Reserve was created in 1967 through the federation of two longstanding contiguous institutions of Western Reserve University, founded in 1826 and named for its location in the Connecticut Western Reserve, and Case Institute of Technology, founded in 1880 through the endowment of Leonard Case Jr.

Source: Crains Cleveland

Pin It on Pinterest